The FDA issued Monday approval for Thoratec Corporation to sell HeartMate II, a blood-pumping device designed for a special category of people.
Thoratec Corporation is a world leader engaged in the research, development, manufacturing and marketing of medical devices for circulatory support, vascular graft, blood coagulation and skin incision applications.
HeartMate II was designed especially for patients who are too slightly built to be implanted with other pumps. It is implanted alongside the natural heart and then removed after the patient gets a heart transplant
HeartMate II is three inches long and weighs about one pound and is reported to pump up to 10 liters of blood per minute.
The preliminary cost of HeartMate II, including batteries and other related equipment, is about $100,000.
Russian Finance Minister Anton Siluanov announced a possible move that Russia can take in response to new US sanctions
Not that long ago, American soldiers would train their skills to counter insurgent and partisan military organizations. These days, they are trained to show resistance to the regular army of a potential adversary
The Central Bank of Turkey announced measures to protect the financial market of Turkey against the background of the collapse of the Turkish lira and conflict of interests with the United States of America